Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1785 of 5804
-
New dialysis system aims to improve kidney care
Disease control Recruiting nowSolv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident di…
Phase: NA • Sponsor: Mozarc Medical US LLC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New breast reconstruction technique uses fat grafting through armpit incision
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical study is to evaluate the effectiveness and safety of a novel breast reconstruction technique combining endoscopic nipple-sparing mastectomy (E-NSM) with immediate multistage fat grafting (IMFG) in female patients aged 18 years or older with clinical stag…
Phase: NA • Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for stubborn gut cancers? early trial launches
Disease control Recruiting nowThis is the first-in-human study of 7MW4911 in US patients, to investigate its prelimary safety and efficacy in patients with gastrointestinal cancers.
Phase: PHASE1, PHASE2 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:27 UTC
-
New telerehab study aims to ease lung cancer Survivors' symptoms
Symptom relief Recruiting nowLung cancer is the second-most commonly diagnosed cancer among U.S. Veterans. Substantial advances have been made in early detection through screening and treatment. The longevity of Veterans following lung cancer diagnosis and treatment has increased. Following treatment however…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Baldness breakthrough? own cells injected into scalp to regrow hair
Disease control Recruiting nowThis is a Phase I/IIa clinical study to evaluate the safety, tolerability, and preliminary efficacy of EPI-001 in patients with androgenetic alopecia. In the Phase I portion, a traditional 3+3 dose-escalation design will be used to determine the maximum tolerated dose (MTD) and …
Phase: PHASE1, PHASE2 • Sponsor: Epibiotech • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New pacemaker promises longer battery, better heart rhythm
Disease control Recruiting nowA third generation, Micra AV2 is now available and proposes increased automaticity and improved AV synchrony algorithms based on computing model. The new algorithms permit the delivery of AV synchronous pacing, improving the automatic AV synchrony at faster heart rates between 80…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study lets smokers choose their own path to quit
Disease control Recruiting nowThis study aims to investigate harm-reduction sampling in a choice format versus medicinal nicotine sampling on smoking behavior, identify mechanisms of sampling's effects, and explore moderators of these effects among a national sample of people unmotivated to quit smoking. Part…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Surgical glue may boost healing for tough anal fistulas
Disease control OngoingHigh anal fistula is a complex anorectal condition that can cause persistent pain, purulent discharge, recurrent infection, and a significant reduction in quality of life. The conventional cutting seton technique is an established treatment modality; however, it may be associated…
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Chemo spray targets Stomach-Lining tumors in pancreatic cancer
Disease control Recruiting nowPalliative systemic therapy is the standard treatment option for patients with pancreatic ductal adenocarcinoma (PDAC) and peritoneal metastasis (PM), who have a median overall survival of only 6-11 months and a serious adverse event (SAE) rate of \>5%. Patients with peritoneal-o…
Phase: PHASE1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Seaweed compound could ease arthritis pain in new trial
Disease control Recruiting nowRheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint destruction and autoantibody production. Scavenger receptor-A (SR-A), a pattern recognition receptor primarily expressed on myeloid-derived cells, is significantly elevated in the serum of RA patient…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could fewer sensors spot sleep apnea in kids?
Diagnosis Recruiting nowDiagnosing obstructive sleep apnea-hypopnea syndrome in children (OSA) requires the performance of polysomnography (PSG) in the hospital which is sometimes challenging to perform in children, and time-consuming for installation and analysis. Simplified recording and analysis meth…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Smartwatch AI could spot dangerous thyroid Flare-Ups
Diagnosis Recruiting nowThis observational study aims to evaluate the performance of a software-based medical device, Glandy HYPER, in detecting the thyrotoxic state in patients with hyperthyroidism. The device utilizes heart rate data collected from commercially available wearable devices and compares …
Sponsor: THYROSCOPE INC. • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Could a simple stool test replace colonoscopy for cancer surveillance?
Diagnosis Recruiting nowFrom observational studies, it is know that the risk of developing colorectal cancer after polyp removal is lower if the patients adheres to surveillance recommendations. However, colonoscopy is burdensome for patients and colonoscopy availability is limited in many parts of the …
Phase: NA • Sponsor: Sorlandet Hospital HF • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New drug duo takes on advanced cancers
Disease control Recruiting nowThis is an open-label, multicenter, Phase Ib/II clinical study designed to evaluate the safety, tolerability, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of FL115 in combination with the anti-PD-1 monoclonal antibody, in participants with advanced solid tumors. All…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
AI reads biopsies to predict cancer spread
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study aims to develop and validate an artificial intelligence-based model using prostate cancer biopsy pathology to predict lymph node metastasis and distant metastasis in patients with prostate cancer. The main questions it aims to answer are: Can artificial …
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Eczema drug afimkibart tested for Long-Term safety in new study
Disease control Recruiting nowThis study will assess long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with Atopic Dermatitis (AD) who participated in previous afimkibart clinical trials.
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New heart lead under watch: 5-Year safety check begins
Disease control ENROLLING_BY_INVITATIONMedtronic is sponsoring the LEADR PAS to provide continuing evaluation and periodic reporting of safety and effectiveness of the OmniaSecure™ defibrillation lead following commercial release. The LEADR PAS is conducted within Medtronic's Product Surveillance Registry Platform (NC…
Sponsor: Medtronic • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New flu shot for seniors put to the test
Prevention Not yet recruitingTo evaluate the immunogenicity of administering one dose of influenza virus split vaccine (0.7mL/dose) to individuals aged 60 and above.
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Robot arm takes on colon surgery: faster, safer removal of growths?
Symptom relief Not yet recruitingThis study aims to compare the outcomes of Simplified Robot (FASTER) assisted Endoscopic Submucosal Dissection (ESD) with conventional ESD in the treatment of colorectal lesions. Using a prospective, single-center, randomized controlled design, the investigators will systematical…
Phase: NA • Sponsor: Kaiyun Liu • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New sickle cell drug DISC-3405 enters early human safety trial
Disease control Recruiting nowThis is an open-label, multicenter, within-participant dose-escalation study examining up to 3 dose levels of DISC-3405 and will assess the safety, tolerability, PK, and PD of DISC 3405 in participants with sickle cell disease.
Phase: PHASE1 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC